世界の免疫療法薬市場2020-2027:新型コロナの影響、種類別(モノクローナル抗体、チェックポイント阻害剤、インターフェロン・インターロイキン・その他免疫療法)、治療領域別、エンドユーザー別、地域別

◆英語タイトル:Global Immunotherapy Drugs Market Size study with COVID-19 Impact, by Type (Monoclonal Antibodies, Checkpoint Inhibitors, Interferons & Interleukins and Other Immunotherapies), by Therapeutic Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases and Others), by End-User (Hospitals, Clinics and Others) and Regional Forecasts 2020-2027
◆商品コード:BZW20JL044
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年6月25日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、英国、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥656,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、免疫療法薬の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、製品別(モノクローナル抗体、チェックポイント阻害剤、インターフェロン・インターロイキン、その他免疫療法)分析、治療領域別分析、エンドユーザー別分析、地域別分析、競争状況、調査プロセスなどを含め、以下の構成でご提供いたします。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場分析
・免疫療法薬の世界市場規模:製品別(モノクローナル抗体、チェックポイント阻害剤、インターフェロン・インターロイキン、その他免疫療法)
・免疫療法薬の世界市場規模:治療領域別
・免疫療法薬の世界市場規模:エンドユーザー別
・免疫療法薬の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Immunotherapy Drugs Market is valued approximately USD 146.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11 % over the forecast period 2020-2027. Immunotherapy drugs are used to enhance the immunity of human body, the drug stimulates the immune system of the body and generate an immune response aiding the production of antibodies that are produced against antigen to kill the cancerous or tumor cells. Immunotherapy Drugs is being highly demanded for enhancing the immune system during the coronavirus pandemic across the world. Furthermore, cancer immunotherapy community is poised to contribute to the current fight against COVID-19. The increasing adoption of immunotherapy drugs over conventional treatment regimens, rising prevalence of cancer and autoimmune & infectious diseases and increasing demand for monoclonal antibodies and biosimilars are the few factors responsible for growth of the market over the forecast period. For instance: as per American Cancer Society, more than 15.5 million cancer cases were reported in January 2016. Later 1.7 million new cases diagnosed in 2018 at U.S. Moreover, the rising advancements in immunotherapy drugs and other strategic alliance by market key players will create a lucrative demand for this market. For instance: in April 2018, Europe based Roche Holdings AG launched monoclonal antibody atezolizumab used for the treatment of small cell lung cancer in India. Whereas, timeline issues, side-effects, and manufacturing complexities are the major factors restraining the growth of global Immunotherapy Drugs market during the forecast period.

The regional analysis of global Immunotherapy Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the increasing prevalence of cancer and autoimmune diseases, rising demand for safer cancer therapies, increasing number of approvals from the FDA, and the introduction of favorable reimbursement policies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Roche Holding AG
Pfizer Inc.
Merck & Co., Inc.
Novartis International AG
Johnson & Johnson
Sanofi S.A.
GlaxoSmithKline plc
AbbVie Inc.
Amgen Inc.
C.H. Boehringer Sohn AG & Co.. KG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Type:
Monoclonal Antibodies
Checkpoint Inhibitors
Interferons & Interleukins
Other Immunotherapies

by Therapeutic Area:
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others

By End-User:
Hospitals
Clinics
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Immunotherapy Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Immunotherapy Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Immunotherapy Drugs Market, by Type, 2018-2027 (USD Billion)
1.2.3. Immunotherapy Drugs Market, by Therapeutic Area, 2018-2027 (USD Billion)
1.2.4. Immunotherapy Drugs Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Immunotherapy Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Immunotherapy Drugs Market Dynamics
3.1. Immunotherapy Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Immunotherapy Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Immunotherapy Drugs Market, by Type
5.1. Market Snapshot
5.2. Global Immunotherapy Drugs Market by Type, Performance – Potential Analysis
5.3. Global Immunotherapy Drugs Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4. Immunotherapy Drugs Market, Sub Segment Analysis
5.4.1. Monoclonal Antibodies
5.4.2. Checkpoint Inhibitors
5.4.3. Interferons & Interleukins
5.4.4. Other Immunotherapies
Chapter 6. Global Immunotherapy Drugs Market, by Therapeutic Area
6.1. Market Snapshot
6.2. Global Immunotherapy Drugs Market by Therapeutic Area, Performance – Potential Analysis
6.3. Global Immunotherapy Drugs Market Estimates & Forecasts by Therapeutic Area 2017-2027 (USD Billion)
6.3.1. Cancer
6.3.2. Autoimmune & Inflammatory Diseases
6.3.3. Infectious Diseases
6.3.4. Others
Chapter 7. Global Immunotherapy Drugs Market, by End-User
7.1. Market Snapshot
7.2. Global Immunotherapy Drugs Market by End-User, Performance – Potential Analysis
7.3. Global Immunotherapy Drugs Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
7.4. Immunotherapy Drugs Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Others
Chapter 8. Global Immunotherapy Drugs Market, Regional Analysis
8.1. Immunotherapy Drugs Market, Regional Market Snapshot
8.2. North America Immunotherapy Drugs Market
8.2.1.1. U.S. Immunotherapy Drugs Market
8.2.1.2. Type breakdown estimates & forecasts, 2017-2027
8.2.1.3. Therapeutic Area breakdown estimates & forecasts, 2017-2027
8.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Immunotherapy Drugs Market
8.3. Europe Immunotherapy Drugs Market Snapshot
8.3.1. U.K. Immunotherapy Drugs Market
8.3.2. Germany Immunotherapy Drugs Market
8.3.3. France Immunotherapy Drugs Market
8.3.4. Spain Immunotherapy Drugs Market
8.3.5. Italy Immunotherapy Drugs Market
8.3.6. Rest of Europe Immunotherapy Drugs Market
8.4. Asia-Pacific Immunotherapy Drugs Market Snapshot
8.4.1. China Immunotherapy Drugs Market
8.4.2. India Immunotherapy Drugs Market
8.4.3. Japan Immunotherapy Drugs Market
8.4.4. Australia Immunotherapy Drugs Market
8.4.5. South Korea Immunotherapy Drugs Market
8.4.6. Rest of Asia Pacific Immunotherapy Drugs Market
8.5. Latin America Immunotherapy Drugs Market Snapshot
8.5.1. Brazil Immunotherapy Drugs Market
8.5.2. Mexico Immunotherapy Drugs Market
8.6. Rest of The World Immunotherapy Drugs Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Roche Holding AG
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Pfizer Inc.
9.2.3. Merck & Co., Inc.
9.2.4. Novartis International AG
9.2.5. Johnson & Johnson
9.2.6. Sanofi S.A.
9.2.7. GlaxoSmithKline plc
9.2.8. AbbVie Inc.
9.2.9. Amgen Inc.
9.2.10. C.H. Boehringer Sohn AG & Co.. KG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

TABLE 1. Global Immunotherapy Drugs market, report scope
TABLE 2. Global Immunotherapy Drugs market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Immunotherapy Drugs market estimates & forecasts by Type 2017-2027 (USD Billion)
TABLE 4. Global Immunotherapy Drugs market estimates & forecasts by Therapeutic Area 2017-2027 (USD Billion)
TABLE 5. Global Immunotherapy Drugs market estimates & forecasts by End-User 2017-2027 (USD Billion)
TABLE 6. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 24. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 26. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 27. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. U.S. Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 29. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Canada Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 33. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. UK Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. Germany Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 41. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. France Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 45. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. Spain Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. Italy Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 53. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. ROE Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 57. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 58. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. China Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 61. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 64. India Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 65. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 67. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Japan Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 69. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 70. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. Australia Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 73. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 76. South Korea Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 77. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 78. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 79. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 80. ROPAC Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 81. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 82. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 83. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 84. Brazil Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 85. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 86. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 87. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 88. Mexico Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 89. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 90. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 91. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 92. ROLA Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 93. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 94. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 95. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 96. ROW Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 97. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 98. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 99. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 100. List of secondary sources, used in the study of global Immunotherapy Drugs market
TABLE 101. List of primary sources, used in the study of global Immunotherapy Drugs market
TABLE 102. Years considered for the study
TABLE 103. Exchange rates considered

FIG 1. Global Immunotherapy Drugs market, research methodology
FIG 2. Global Immunotherapy Drugs market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Immunotherapy Drugs market, key trends 2019
FIG 5. Global Immunotherapy Drugs market, growth prospects 2020-2027
FIG 6. Global Immunotherapy Drugs market, porters 5 force model
FIG 7. Global Immunotherapy Drugs market, pest analysis
FIG 8. Global Immunotherapy Drugs market, value chain analysis
FIG 9. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 18. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 19. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
FIG 20. Global Immunotherapy Drugs market, regional snapshot 2017 & 2027
FIG 21. North America Immunotherapy Drugs market 2017 & 2027 (USD Billion)
FIG 22. Europe Immunotherapy Drugs market 2017 & 2027 (USD Billion)
FIG 23. Asia Pacific Immunotherapy Drugs market 2017 & 2027 (USD Billion)
FIG 24. Latin America Immunotherapy Drugs market 2017 & 2027 (USD Billion)
FIG 25. Global Immunotherapy Drugs market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の免疫療法薬市場2020-2027:新型コロナの影響、種類別(モノクローナル抗体、チェックポイント阻害剤、インターフェロン・インターロイキン・その他免疫療法)、治療領域別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆